Reduced mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of soft tissue sarcoma

Carcinogenesis

Volumn 34, Issue 5, 2013, Pages 1039-1043

  Xie, Hui ^a,b   Lev, Dina ^a   Gong, Yilei ^a   Wang, Shui ^c   Pollock, Raphael E ^a   Wu, Xifeng ^a   Gu, Jian ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SMOKING; SOFT TISSUE SARCOMA;

CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; DNA COPY NUMBER VARIATIONS; DNA, MITOCHONDRIAL; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; SARCOMA;

EID: 84877104879     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt023     Document Type: Article

References (53)

1. van der Graaf,W.T. et al. (2012) Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 379, 1879-1886.
2. Siegel,R. et al. (2012) Cancer statistics, 2012. CA Cancer J. Clin., 62, 10-29.
3. Schoffski,P. et al. (2011) Activity of eribulin mesylate in patients with softtissue sarcoma: a phase 2 study in four independent histological subtypes. Lancet Oncol., 12, 1045-1052.
4. Coindre,J.M. et al. (2001) Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer, 91, 1914-1926.
5. Howlader,N. et al. (eds) (2012). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site.
6. Green,D.R. et al. (2011) Mitochondria and the autophagy-inflammationcell death axis in organismal aging. Science, 333, 1109-1112.
7. Mitra,K. et al. (2009) A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase. Proc. Natl Acad. Sci. U.S.A., 106, 11960-11965.
8. Zhou,R. et al. (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature, 469, 221-225.
9. Rambold,A.S. et al. (2011) Cell biology. SevERing mitochondria. Science, 334, 186-187.
10. Fernandez-Silva,P. et al. (2003) Replication and transcription of mammalian mitochondrial DNA. Exp. Physiol., 88, 41-56.
11. Chan,D.C. (2006) Mitochondria: dynamic organelles in disease, aging, and development. Cell, 125, 1241-1252.
12. Lee,H.C. et al. (2005) Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int. J. Biochem. Cell Biol., 37, 822-834.
13. Wallace,D.C. (1994) Mitochondrial DNA sequence variation in human evolution and disease. Proc. Natl Acad. Sci. U.S.A., 91, 8739-8746.
14. Veltri,K.L. et al. (1990) Distinct genomic copy number in mitochondria of different mammalian organs. J. Cell. Physiol., 143, 160-164.
15. Clay Montier,L.L. et al. (2009) Number matters: control of mammalian mitochondrial DNA copy number. J. Genet. Genomics, 36, 125-131.
16. Shen,J. et al. (2010) Mitochondrial copy number and risk of breast cancer: a pilot study. Mitochondrion, 10, 62-68.
17. Potenza,L. et al. (2011) Effect of surgical stress on nuclear and mitochondrial DNA from healthy sections of colon and rectum of patients with colorectal cancer. J. Biosci., 36, 243-251.
18. Egan,K. et al. (2010) Mitochondrial DNA in residual leukemia cells in cerebrospinal fluid in children with acute lymphoblastic leukemia. J. Clin. Med. Res., 2, 225-229.
19. Kusao,I. et al. (2008) Chemotoxicity recovery of mitochondria in non-Hodgkin lymphoma resulting in minimal residual disease. Pediatr. Blood Cancer, 51, 193-197.
20. Chen,T. et al. (2011) The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer. BMC Med. Genet., 12, 8.
21. Lin,C.S. et al. (2010) The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas. J. Thorac. Cardiovasc. Surg., 139, 189-197.e4.
22. Kim,M.M. et al. (2004) Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin. Cancer Res., 10, 8512-8515.
23. Wang,Y. et al. (2006) Association of decreased mitochondrial DNA content with ovarian cancer progression. Br. J. Cancer, 95, 1087-1091.
24. Wang,Y. et al. (2005) The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Gynecol. Oncol., 98, 104-110.
25. Mambo,E. et al. (2005) Tumor-specific changes in mtDNA content in human cancer. Int. J. Cancer, 116, 920-924.
26. Mizumachi,T. et al. (2008) Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells. Prostate, 68, 408-417.
27. Lee,H.C. et al. (2005) Mitochondrial genome instability and mtDNA depletion in human cancers. Ann. N. Y. Acad. Sci., 1042, 109-122.
28. Fan,A.X. et al. (2009) Mitochondrial DNA content in paired normal and cancerous breast tissue samples from patients with breast cancer. J. Cancer Res. Clin. Oncol., 135, 983-989.
29. Tseng,L.M. et al. (2006) Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer, 45, 629-638.
30. Yu,M. et al. (2007) Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients. IUBMB Life, 59, 450-457.
31. Vivekanandan,P. et al. (2010) Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas. Mod. Pathol., 23, 790-798.
32. Yamada,S. et al. (2006) Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma. Eur. J. Surg. Oncol., 32, 303-307.
33. Lee,H.C. et al. (2004) Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat. Res., 547, 71-78.
34. Yin,P.H. et al. (2004) Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br. J. Cancer, 90, 2390-2396.
35. Lin,C.S. et al. (2008) Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy. Interact. Cardiovasc. Thorac. Surg., 7, 954-958.
36. Horton,T.M. et al. (1996) Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes Chromosomes Cancer, 15, 95-101.
37. Meierhofer,D. et al. (2004) Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis, 25, 1005-1010.
38. Zhao,S.Y. et al. (2011) Association of mitochondrial DNA content in peripheral blood leukocyte with hepatitis B virus-related hepatocellular carcinoma in a Chinese Han population. Cancer Sci., 102, 1553-1558.
39. Xing,J. et al. (2008) Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J. Natl Cancer Inst., 100, 1104-1112.
40. Thyagarajan,B. et al. (2012) Mitochondrial copy number is associated with colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev., 21, 1574-1581.
41. Hosgood,H.D. 3rd et al. (2010) Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study. Carcinogenesis, 31, 847-849.
42. Lan,Q. et al. (2008) A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma. Blood, 112, 4247-4249.
43. Kaaman,M. et al. (2007) Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue. Diabetologia, 50, 2526-2533.
44. Weber,J.L. et al. (1989) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. Hum. Genet., 44, 388-396.
45. Assaily,W. et al. (2006) Differential utilization of two ATP-generating pathways is regulated by p53. Cancer Cell, 10, 4-6.
46. Warburg,O. (1956) On the origin of cancer cells. Science, 123, 309-314.
47. Chandel,N.S. et al. (1999) Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms. FEBS Lett., 454, 173-176.
48. Naito,A. et al. (2008) Progressive tumor features accompany epithelialmesenchymal transition induced in mitochondrial DNA-depleted cells. Cancer Sci., 99, 1584-1588.
49. Huber,M.A. et al. (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol., 17, 548-558.
50. Ducut Sigala,J.L. et al. (2004) Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science, 304, 1963-1967.
51. Yu,M. et al. (2012) Cell-free circulating mitochondrial DNA in serum: a potential non-invasive biomarker for Ewing's sarcoma. Arch. Med. Res., 43, 389-394.
52. Yu,M. et al. (2010) Decreased copy number of mitochondrial DNA in Ewing's sarcoma. Clin. Chim. Acta, 411, 679-683.
53. Masayesva,B.G. et al. (2006) Mitochondrial DNA content increase in response to cigarette smoking. Cancer Epidemiol. Biomarkers Prev., 15, 19-24.